The center is slated to open in 2014.
Dr. Colombel also serves as a professor of medicine and gastroenterology at the Icahn School of Medicine at Mount Sinai. He is renowned for his role in identifying NOD2 as a susceptibility gene for Crohn’s disease and the identification of a new subtype of E. coli associated with Crohn’s.
Dr. Colombel has authored more than 500 peer-reviewed articles, books and chapters on inflammatory bowel disease. Recently he also was a professor of hepatogastroenterology at Centre Hospitalier Universitaire de Lille in France and the president of the European Crohn’s and Colitis Organization.
More Articles on Gastroenterology:
Hallmark Health’s New Gastroenterology Location Opens in Massachusetts
Kansas Hospital Tests Patients for Hepatitis, HIV After Administering Colonoscopies With Potentially Contaminated Scopes
Dr. Dennis Yamamoto of Digestive Health Associates Named a Top 100 Influential Figure
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.